Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Other hematologic neoplasm 4Genitourinary 3Thoracic 2Myeloid 2Gastrointestinal 2Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 100Leukemia, Myeloid, Acute 93Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Myeloproliferative Disorders 71Multiple Myeloma 65Lymphoma, Non-Hodgkin 62Leukemia 62Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Leukemia, Lymphocytic, Chronic, B-Cell 58Hodgkin Disease 58Primary Myelofibrosis 52Lymphoma, Mantle-Cell 45Lymphoma, Large B-Cell, Diffuse 42Burkitt Lymphoma 42Lymphoma, Follicular 41Leukemia, Myeloid, Chronic-Phase 40Lymphoma, B-Cell, Marginal Zone 39Lymphoma 39Lymphoma, Large-Cell, Immunoblastic 38Congenital Abnormalities 37Lymphoma, T-Cell, Cutaneous 35Leukemia, Myeloid, Accelerated Phase 35Sezary Syndrome 32Mycosis Fungoides 32Leukemia, Myelomonocytic, Chronic 32Blast Crisis 32Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28Pdgfra-Associated Chronic Eosinophilic Leukemia 27Leukemia, Neutrophilic, Chronic 27Neoplasms, Plasma Cell 26

Interventions

Pharmaceutical Services 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Medication Adherence × Myeloid × Clear all
NCT03090477 2019-04-05

Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients

UCSI University

Phase NA Completed
129 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Medication Adherence

NCT01768689 2017-06-07

TAKE-IT

Rabin Medical Center

Phase NA Completed
58 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡